Triton completes investment in Bergman Clinics
Frankfurt (Germany), Naarden (Netherlands), 19 August 2021 - Triton Fund V advised by Triton (“Triton”) has successfully completed its investment in Bergman Clinics (“Bergman Clinics”), one of the leading chains of independent clinics in the Netherlands, Germany and Scandinavia. Triton invested in partnership with the current shareholders consisting of the Malenstein family and NPM Capital. Terms and conditions of the transaction are not disclosed.
Bergman Clinics is a leading specialist for treatments in the field of orthopedics, ophthalmology, gynecology, aesthetic medicine, cardiology, gastroenterology, dermatology, and vascular medicine. Bergman Clinics grew its network of clinics through an active acquisition strategy, first in the Dutch home market, later on in Scandinavia and Germany. Bergman Clinics currently owns 140 focus clinics throughout the Netherlands, Sweden, Denmark, Norway, and Germany which offer high quality, plannable medical care, with clients and their conditions at the heart of their activities.
The investment by Triton will help Bergman Clinics to further expand its geographical footprint, and creates room to invest in technological innovation, digitization and training. Both clients and employees can benefit directly from this.
About Bergman Clinics
For nearly 30 years, Bergman Clinics has been one of the leading chains of independent clinics with 140 focus clinics throughout the Netherlands, Sweden, Denmark, Norway, and Germany. The focus clinics offer high quality, plannable medical care, with patients and the condition at the core. Bergman Clinics is a leading specialist for treatments in the field of orthopedics, ophthalmology, gynecology, aesthetic medicine, cardiology, gastroenterology, dermatology, and vascular medicine. Bergman Clinics treats more than 300,000 patients every year in the Netherlands, Germany, and Scandinavia. More than 3,000 employees and more than 250 specialists work at Bergman Clinics.
For more information: https://www.bergmanclinics.nl/
Since its establishment in 1997, Triton has sponsored ten funds, focusing on businesses in the industrial & technology, services, consumer and health sectors. The Triton funds invest in and support the positive development of medium-sized businesses headquartered in Europe.
Triton seeks to contribute to the building of better businesses for the longer term. Triton and its executives wish to be agents of positive change towards sustainable operational improvement and growth.
The 49 companies currently in Triton's portfolio have combined sales of around EUR 18 billion and employ around 104,000 employees.
For more information: www.triton-partners.com